Shenzhen - Delayed Quote CNY

Jiangsu Apon Medical Technology Co., Ltd. (300753.SZ)

11.47 -0.42 (-3.53%)
As of 2:43 PM GMT+8. Market Open.
Loading Chart for 300753.SZ
DELL
  • Previous Close 11.89
  • Open 11.78
  • Bid 11.47 x --
  • Ask 11.48 x --
  • Day's Range 11.35 - 12.06
  • 52 Week Range 7.98 - 20.00
  • Volume 2,516,503
  • Avg. Volume 5,401,589
  • Market Cap (intraday) 1.446B
  • Beta (5Y Monthly) 0.25
  • PE Ratio (TTM) 163.86
  • EPS (TTM) 0.07
  • Earnings Date --
  • Forward Dividend & Yield 0.07 (0.54%)
  • Ex-Dividend Date Jun 3, 2024
  • 1y Target Est --

Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care. Jiangsu Apon Medical Technology Co., Ltd. was founded in 2001 and is headquartered in Nantong, China.

www.apon.com.cn

590

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 300753.SZ

Performance Overview: 300753.SZ

Trailing total returns as of 6/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

300753.SZ
32.83%
SSE Composite Index
3.28%

1-Year Return

300753.SZ
41.61%
SSE Composite Index
4.88%

3-Year Return

300753.SZ
53.46%
SSE Composite Index
14.59%

5-Year Return

300753.SZ
48.79%
SSE Composite Index
5.99%

Compare To: 300753.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 300753.SZ

Valuation Measures

Annual
As of 5/31/2024
  • Market Cap

    1.51B

  • Enterprise Value

    1.45B

  • Trailing P/E

    178.62

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.61

  • Price/Book (mrq)

    2.16

  • Enterprise Value/Revenue

    3.49

  • Enterprise Value/EBITDA

    88.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.02%

  • Return on Assets (ttm)

    0.11%

  • Return on Equity (ttm)

    1.20%

  • Revenue (ttm)

    415.86M

  • Net Income Avi to Common (ttm)

    8.42M

  • Diluted EPS (ttm)

    0.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    140.94M

  • Total Debt/Equity (mrq)

    12.09%

  • Levered Free Cash Flow (ttm)

    -64.33M

Research Analysis: 300753.SZ

Company Insights: 300753.SZ

Research Reports: 300753.SZ

People Also Watch